Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.4000
0.00 (0.00%)
Aug 10, 2026, 12:07 PM EST
Defence Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -6.05 | -3.52 | -13.19 | -6.76 | -7.34 | -2.86 |
Depreciation & Amortization | 0.05 | 0.07 | 0.09 | 0.01 | - | - |
Stock-Based Compensation | 0.36 | 0.79 | 5.84 | 0.3 | 0.37 | 0.61 |
Other Operating Activities | 1.66 | 0.24 | 0.4 | 0.16 | - | - |
Change in Accounts Receivable | -0.23 | -0.1 | 0.05 | -0.12 | 0.04 | - |
Change in Accounts Payable | -0.32 | -0.91 | 2.1 | -0.89 | 0.98 | 0.07 |
Change in Other Net Operating Assets | -0.01 | 0.03 | 0.43 | -0.35 | -0.1 | -0.11 |
Operating Cash Flow | -4.53 | -3.4 | -4.29 | -7.66 | -6.04 | -2.29 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Capital Expenditures | -0.02 | - | -0.2 | -0.07 | - | - |
Sale of Property, Plant & Equipment | -0.01 | 0 | - | - | - | - |
Investing Cash Flow | -0.03 | 0 | -0.2 | -0.07 | - | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Short-Term Debt Issued | - | 0.02 | 0.05 | - | - | - |
Long-Term Debt Issued | - | - | - | 2.36 | - | - |
Total Debt Issued | 2 | 0.02 | 0.05 | 2.36 | - | - |
Short-Term Debt Repaid | - | -0.07 | - | - | - | - |
Long-Term Debt Repaid | - | -0.12 | -0.06 | - | - | - |
Total Debt Repaid | -0.02 | -0.18 | -0.06 | - | - | - |
Net Debt Issued (Repaid) | 1.98 | -0.17 | -0.01 | 2.36 | - | - |
Issuance of Common Stock | 3.62 | 5.02 | 1.89 | 8.25 | 1.1 | 2.76 |
Other Financing Activities | -0.17 | -0.28 | -0.12 | -0.59 | - | 3.12 |
Financing Cash Flow | 5.44 | 4.57 | 1.76 | 10.01 | 1.1 | 5.88 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Foreign Exchange Rate Adjustments | -0 | 0 | - | - | - | - |
Net Cash Flow | 0.87 | 1.18 | -2.74 | 2.29 | -4.95 | 3.59 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -4.55 | -3.4 | -4.49 | -7.72 | -6.04 | -2.29 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.08 | -0.07 | -0.10 | -0.20 | -0.17 | -0.09 |
Levered Free Cash Flow | -2.6 | -2.31 | 0.09 | -5.34 | -3.25 | -1.2 |
Unlevered Free Cash Flow | -2.42 | -2.11 | 0.34 | -5.18 | -3.25 | -1.2 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash Interest Paid | - | 0 | 0.04 | 0.01 | - | - |
Change in Working Capital | -0.55 | -0.99 | 2.58 | -1.36 | 0.93 | -0.04 |